Emylif 50 mg

Emylif 50 mg is a medicine authorised by Swissmedic under authorisation number 68915. The authorisation holder is Zambon Svizzera SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 November 2023 and the authorisation is limited until 16 November 2028. ATC code N07XX02 places the medicine in the group Other nervous system drugs.

  • Dispensing category B
  • Authorisation number 68915
  • ATC N07XX02
  • Synthetic medicines
Authorisation data
Authorisation number68915
NameEmylif 50 mg
Full nameEmylif 50 mg, film orodispersibile
Authorisation holderZambon Svizzera SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN07XX02
First authorisation17 November 2023
Authorisation validity16 November 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Emylif 50 mg, film orodispersibileB17 November 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156StückN07XX0201.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Emylif 50 mg authorised in Switzerland?

Yes. Emylif 50 mg is authorised by Swissmedic under authorisation number 68915, data as of 01 September 2026. The authorisation is limited until 16 November 2028.

Which dispensing category does Emylif 50 mg have?

Emylif 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Emylif 50 mg?

The authorisation holder is Zambon Svizzera SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com